Dr. Reddy's Laboratories Company Profile (NYSE:RDY)

About Dr. Reddy's Laboratories

Dr. ReddyDr. Reddy's Laboratories Limited is an integrated global pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Global Generics segment consists of its business of manufacturing and marketing prescription and over-the-counter (OTC) finished pharmaceutical products, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company's business of manufacturing and marketing active pharmaceutical ingredients (API) and intermediates. Proprietary Products segment consists of its differentiated formulations business, its new chemical entities (NCEs) business and its dermatology focused specialty business. The Company's OTC brands include Doan's, Bufferin, Nupercainal Ointment, Cruex Nail Gel, Comtrex and Myoflex.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: RDY
  • CUSIP:
Key Metrics:
  • Previous Close: $47.83
  • 50 Day Moving Average: $46.17
  • 200 Day Moving Average: $46.70
  • 52-Week Range: $40.67 - $68.00
  • Trailing P/E Ratio: 36.43
  • Foreward P/E Ratio: 21.55
  • P/E Growth: 1.69
  • Market Cap: $7.92B
  • Outstanding Shares: 165,530,000
  • Beta: 0.83
Profitability:
  • Net Margins: 10.09%
  • Return on Equity: 12.27%
  • Return on Assets: 7.43%
Debt:
  • Debt-to-Equity Ratio: 0.10%
  • Current Ratio: 1.52%
  • Quick Ratio: 1.10%
Additional Links:
Companies Related to Dr. Reddy's Laboratories:

Analyst Ratings

Consensus Ratings for Dr. Reddy's Laboratories (NYSE:RDY) (?)
Ratings Breakdown: 4 Sell Ratings, 3 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 1.63)
Consensus Price Target: $41.90 (12.40% downside)

Analysts' Ratings History for Dr. Reddy's Laboratories (NYSE:RDY)
Show:
DateFirmActionRatingPrice TargetDetails
7/27/2016HSBCDowngradeHold -> ReduceView Rating Details
7/27/2016Jefferies GroupDowngradeHold -> Underperform$45.00 -> $41.90View Rating Details
7/26/2016Credit Suisse Group AGDowngradeNeutral -> UnderperformView Rating Details
5/2/2016Goldman Sachs Group Inc.Initiated CoverageNeutralView Rating Details
2/10/2016Credit Agricole SAUpgradeUnderperform -> BuyView Rating Details
12/2/2015Deutsche Bank AGInitiated CoverageSellView Rating Details
11/10/2015Citigroup Inc.DowngradeBuy -> NeutralView Rating Details
11/6/2015Barclays PLCDowngradeOverweight -> Equal WeightView Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for Dr. Reddy's Laboratories (NYSE:RDY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2016Q117$0.00$557.00 million$479.00 millionViewListenView Earnings Details
5/12/2016Q416$0.07$2.41 billion$567.00 billionViewListenView Earnings Details
2/9/2016Q316$0.51$2.48 million$599.00 millionViewN/AView Earnings Details
10/29/2015Q116$0.65$2.54 billionViewListenView Earnings Details
5/12/2015Q415$0.49$559.00 million$621.00 millionViewListenView Earnings Details
1/29/2015Q315$0.53$561.00 million$610.00 millionViewN/AView Earnings Details
7/30/2014Q115$0.54$474.00 million$486.00 millionViewN/AView Earnings Details
5/13/2014Q414$0.52$0.47$557.00 million$580.00 millionViewN/AView Earnings Details
2/11/2014Q314$0.45$0.59$558.20 million$571.00 millionViewN/AView Earnings Details
10/31/2013Q214$0.46$0.65$561.00 million$537.00 millionViewN/AView Earnings Details
7/30/2013Q413$0.43$0.40$551.40 million$478.00 millionViewN/AView Earnings Details
5/14/2013$0.60ViewN/AView Earnings Details
2/14/2013Q313$0.40$505.00 million$522.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Dr. Reddy's Laboratories (NYSE:RDY)
Current Year EPS Consensus Estimate: $1.33 EPS
Next Year EPS Consensus Estimate: $2.22 EPS

Dividends

Current Dividend Information for Dr. Reddy's Laboratories (NYSE:RDY)
Annual Dividend:$0.28
Dividend Yield:0.59%
Dividend Growth:8.80% (3 Year Average)
Payout Ratio:21.05% (Based on Trailing 12 Months of Earnings)
21.05% (Based on Current Year Consensus EPS Estimate)
12.61% (Based on Next Year Consensus EPS Estimate)
Track Record:2 Years of Consecutive Dividend Growth

Dividend History for Dr. Reddy's Laboratories (NYSE:RDY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/6/2016Annual$0.287/14/20167/18/20167/18/2016
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Dr. Reddy's Laboratories (NYSE:RDY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Dr. Reddy's Laboratories (NYSE:RDY)
DateHeadline
investornewswire.com logoCan Shares Of Dr. Reddy's Laboratories Ltd (NYSE:RDY) Hit $56? - Investor Newswire (NYSE:RDY)
www.investornewswire.com - September 27 at 6:52 PM
News IconBuy Dr. Reddy's Laboratories, target Rs 3310: Siddarth Bhamre (NYSE:RDY)
economictimes.indiatimes.com - September 27 at 11:39 AM
capitalcube.com logoETF’s with exposure to Dr. Reddy’s Laboratories Ltd. : September 26, 2016 (NYSE:RDY)
www.capitalcube.com - September 26 at 11:51 AM
News IconDr Reddys Laboratories Ltd allots 13188 Equity Shares on exercise of ESOP (NYSE:RDY)
www.equitybulls.com - September 24 at 11:24 AM
News IconAnalyst Views and Growth Review for Dr. Reddy's Laboratories Ltd. (NYSE:RDY) - Post News (NYSE:RDY)
www.kentuckypostnews.com - September 23 at 11:43 AM
kcregister.com logoActive Watch List: Harley-Davidson (NYSE:HOG), Symantec Corporation (NASDAQ:SYMC), Dr. Reddy's Laboratories ... - KC Register (NYSE:RDY)
www.kcregister.com - September 22 at 11:48 AM
News IconDr. Reddy's Laboratories Launches Generic Version of Zemplar in U.S. (NYSE:RDY) - Post News (NYSE:RDY)
www.kentuckypostnews.com - September 21 at 6:35 PM
News IconDr Reddy’s Laboratories launches Paricalcitol injection in the US Market (NYSE:RDY)
rtn.asia - September 21 at 11:03 AM
investornewswire.com logoShares Of Dr. Reddy's Laboratories Ltd (NYSE:RDY) Expected To Hit $56 - Investor Newswire (NYSE:RDY)
www.investornewswire.com - September 19 at 6:57 PM
businesswire.com logoDr. Reddy's Laboratories Announces the Launch of Paricalcitol ... - Business Wire (press release) (NYSE:RDY)
www.businesswire.com - September 19 at 6:57 PM
News IconDr. Reddy's Laboratories Announces the Launch of Paricalcitol Injection in the U.S. Market - Yahoo Sports (NYSE:RDY)
sports.yahoo.com - September 19 at 11:33 AM
News IconVigorous Stocks Need to Consider: General Electric (NYSE:GE), Dr ... - Street Wise Report (press release) (blog) (NYSE:RDY)
streetwisereport.com - September 19 at 11:33 AM
publicnow.com logoDr. Reddy's Laboratories announces the launch of Paricalcitol Injection in the U.S. Market (NYSE:RDY)
www.publicnow.com - September 19 at 11:33 AM
streetinsider.com logoDr. Reddys Labs (RDY), Amgen (AMGN) Enter Expanded Collaboration in India - StreetInsider.com (NYSE:RDY)
www.streetinsider.com - September 18 at 11:12 AM
News IconDr Reddy’s to commercialise 3 drugs of Amgen in Indian market (NYSE:RDY)
www.thehindubusinessline.com - September 16 at 6:46 PM
seekingalpha.com logoDr. Reddy's to distribute three new Amgen products in India (NYSE:RDY)
seekingalpha.com - September 16 at 10:34 AM
rttnews.com logoDr. Reddy's Expands Collaboration To Market Amgen's 3 Medicines In India (NYSE:RDY)
www.rttnews.com - September 16 at 10:34 AM
publicnow.com logoDr. Reddy’s Expands Strategic Collaboration with Amgen in India (NYSE:RDY)
www.publicnow.com - September 16 at 10:34 AM
News IconDr Reddys Laboratories Ltd listed on Dow Jones Sustainability Indices 2016 - Equity Bulls (NYSE:RDY)
equitybulls.com - September 15 at 10:35 AM
finance.yahoo.com logoDr. Reddy's Listed on Dow Jones Sustainability Indices 2016 - Yahoo Finance (NYSE:RDY)
finance.yahoo.com - September 15 at 10:35 AM
4-traders.com logoDr Reddy Laboratories : listed on Dow Jones Sustainability Indices 2016 (NYSE:RDY)
www.4-traders.com - September 14 at 7:08 PM
News IconDr Reddys Laboratories Ltd listed on Dow Jones Sustainability Indices 2016 (NYSE:RDY)
www.equitybulls.com - September 14 at 7:08 PM
News IconAnalyst Expectations and Growth Review for Dr. Reddy's Laboratories Ltd. (NYSE:RDY) - Post News (NYSE:RDY)
www.kentuckypostnews.com - September 14 at 11:22 AM
publicnow.com logoDr Reddy’s listed on Dow Jones Sustainability Indices 2016 (NYSE:RDY)
www.publicnow.com - September 14 at 11:22 AM
investornewswire.com logoCan Shares Of Dr. Reddy's Laboratories Ltd (NYSE:RDY) Hit $56 - Investor Newswire (NYSE:RDY)
www.investornewswire.com - September 13 at 11:52 AM
businesswire.com logoDr. Reddy's Listed on Dow Jones Sustainability Indices 2016 - Business Wire (press release) (NYSE:RDY)
www.businesswire.com - September 13 at 11:52 AM
finance.yahoo.com logoDr. Reddy’s Listed on Dow Jones Sustainability Indices 2016 (NYSE:RDY)
au.finance.yahoo.com - September 13 at 11:52 AM
News IconBuy Dr. Reddy's Laboratories Ltd., target Rs 3300.0 : Reliance Securities (NYSE:RDY)
economictimes.indiatimes.com - September 12 at 11:40 AM
News IconAnalyst Projections and Growth Review for Dr. Reddy's Laboratories Ltd. (NYSE:RDY) - Post News (NYSE:RDY)
www.kentuckypostnews.com - September 7 at 10:35 AM
News IconDr. Reddy's announces Purple Health, a unique patient-centric platform that takes care beyond the pill (NYSE:RDY)
www.equitybulls.com - September 6 at 11:46 AM
livemint.com logoDr Reddy’s Laboratories to redesign packaging of its brands (NYSE:RDY)
www.livemint.com - September 2 at 6:54 PM
finance.yahoo.com logo12:01 pm Dr. Reddy's launches Bupropion HCl extended-release tablets in the United States (NYSE:RDY)
finance.yahoo.com - September 2 at 6:54 PM
businesswire.com logoDr. Reddy's Laboratories Announces the Launch of Bupropion HCl Extended-Release Tablets, USP (SR) in the US ... - Business Wire (press release) (NYSE:RDY)
www.businesswire.com - September 2 at 11:56 AM
finance.yahoo.com logoDr. Reddy's Laboratories Announces the Launch of Bupropion HCl Extended-Release Tablets, USP (SR) in the U.S. Market (NYSE:RDY)
au.finance.yahoo.com - September 2 at 11:56 AM
nasdaq.com logoRDY Makes Bullish Cross Above Critical Moving Average (NYSE:RDY)
www.nasdaq.com - September 1 at 10:09 AM
News IconBuy Dr. Reddy's Laboratories Ltd., target Rs 3300.0 : Tejas Shah (NYSE:RDY)
economictimes.indiatimes.com - September 1 at 10:09 AM
News IconDr. Reddys Announces Purple Health, a Unique Patient-Centric Platform That Takes Care beyond the Pill (NYSE:RDY)
www.newson6.com - September 1 at 10:09 AM
publicnow.com logoDr. Reddy’s announces Purple Health, a unique patient-centric platform that takes care beyond the pill (NYSE:RDY)
www.publicnow.com - September 1 at 10:09 AM
nasdaq.com logoRDY Makes Bullish Cross Above Critical Moving Average - Nasdaq (NYSE:RDY)
www.nasdaq.com - August 30 at 6:56 PM
investornewswire.com logoCan Shares Of Dr. Reddy's Laboratories Ltd (NYSE:RDY) Get To $56? - Investor Newswire (NYSE:RDY)
www.investornewswire.com - August 30 at 6:56 PM
streetinsider.com logoForm 6-K DR REDDYS LABORATORIES For: Aug 30 - StreetInsider.com (NYSE:RDY)
www.streetinsider.com - August 30 at 6:56 PM
finance.yahoo.com logoDr. Reddy's Laboratories Launches Nitroglycerin Sublingual Tablets USP in the U.S. Market Hyderabad, India, August ... - Yahoo Finance (NYSE:RDY)
finance.yahoo.com - August 30 at 6:56 PM
News IconBuy Dr. Reddy's Laboratories Ltd., target Rs 3125.0 : Dr CK Narayan (NYSE:RDY)
economictimes.indiatimes.com - August 30 at 10:19 AM
News IconDr. Reddy's launches Nitroglycerin sublingual tablets in US (NYSE:RDY)
health.economictimes.indiatimes.com - August 29 at 6:50 PM
News IconDr. Reddy’s Laboratories launches heart drug in the US (NYSE:RDY)
rtn.asia - August 29 at 6:50 PM
News IconDr. Reddy's Laboratories Launches Nitroglycerin Sublingual Tablets USP in the U.S. ... (NYSE:RDY)
www.biomedreports.com - August 29 at 6:50 PM
seekingalpha.com logoDr. Reddy's launches generic nitroglycerin tablets in U.S. (NYSE:RDY)
seekingalpha.com - August 29 at 6:50 PM
rttnews.com logoDr. Reddy's Labs Launches Nitroglycerin Sublingual Tablets USP (NYSE:RDY)
www.rttnews.com - August 29 at 6:50 PM
streetinsider.com logoDr. Reddys Labs (RDY) Announces U.S. Launch of Generic Nitrostat Tabs (NYSE:RDY)
www.streetinsider.com - August 29 at 6:50 PM
News IconDr. Reddy's Laboratories Launches ... (NYSE:RDY)
www.advfn.com - August 29 at 6:50 PM

Social

Dr. Reddy's Laboratories (NYSE:RDY) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff